— Know what they know.
Not Investment Advice

VNRX AMEX

VolitionRX Ltd
1W: -9.3% 1M: -37.6% 3M: -82.6% YTD: -13.9% 1Y: -62.2% 3Y: -67.6% 5Y: -92.8%
$0.23
+0.00 (+0.13%)
 
Weekly Expected Move ±9.8%
$0 $0 $0 $0 $0
AMEX · Healthcare · Medical - Devices · Tech Score Sell · Power 35 · $2.0M mcap · 7M float · 89.60% daily turnover · Short 42% of daily vol

Income Trends

Revenue
$1M +59.1% ▲
5Y CAGR: +135.3%
Gross Profit
$1M +59.1% ▲
5Y CAGR: +135.3%
Operating Income
-$27M +24.9% ▲
Net Income
-$27M +23.6% ▲
EPS (Diluted)
$-0.31 +38.0% ▲
EBITDA
-$26M +24.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$13K$90K$306K$775K$1M
YoY Growth-21.4%+570.3%+240.3%+153.0%+59.1%
Cost of Revenue$0$0$0$0$0
Gross Profit$13K$90K$306K$775K$1M
Gross Margin100.0%100.0%100.0%100.0%100.0%
R&D Expenses$15M$13M$15M$20M$14M
SG&A Expenses$7M$15M$16M$17M$14M
Operating Expenses$21M$28M$32M$37M$28M
Operating Income-$21M-$28M-$32M-$36M-$27M
Operating Margin-158176.2%-31469.0%-10372.4%-4641.8%-2190.9%
Interest Expense$130K$156K$173K$222K$340K
Income Before Tax-$20M-$27M-$31M-$36M-$27M
Tax Expense$0$0$0$0$0
Net Income-$20M-$27M-$30M-$35M-$27M
Net Margin-151508.3%-29782.5%-9879.1%-4555.5%-2186.3%
EPS (Diluted)$-0.45$-0.51$-0.55$-0.50$-0.31
EBITDA-$19M-$26M-$29M-$34M-$26M
Shares Outstanding45M53M55M71M87M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms